Increased Intestinal Permeability Is Associated With Later Development of Crohn's Disease.


Journal

Gastroenterology
ISSN: 1528-0012
Titre abrégé: Gastroenterology
Pays: United States
ID NLM: 0374630

Informations de publication

Date de publication:
12 2020
Historique:
received: 02 04 2020
revised: 21 07 2020
accepted: 04 08 2020
pubmed: 14 8 2020
medline: 16 4 2021
entrez: 14 8 2020
Statut: ppublish

Résumé

Increased intestinal permeability has been associated with Crohn's disease (CD), but it is not clear whether it is a cause or result of the disease. We performed a prospective study to determine whether increased intestinal permeability is associated with future development of CD. We assessed the intestinal permeability, measured by the urinary fractional excretion of lactulose-to-mannitol ratio (LMR) at recruitment in 1420 asymptomatic first-degree relatives (6-35 years old) of patients with CD (collected from 2008 through 2015). Participants were then followed up for a diagnosis of CD from 2008 to 2017, with a median follow-up time of 7.8 years. We analyzed data from 50 participants who developed CD after a median of 2.7 years during the study period, along with 1370 individuals who remained asymptomatic until October 2017. We used the Cox proportional hazards model to evaluate time-related risk of CD based on the baseline LMR. An abnormal LMR (>0.03) was associated with a diagnosis of CD during the follow-up period (hazard ratio, 3.03; 95% CI, 1.64-5.63; P = 3.97 × 10 Increased intestinal permeability is associated with later development of CD; these findings support a model in which altered intestinal barrier function contributes to pathogenesis. Abnormal gut barrier function might serve as a biomarker for risk of CD onset.

Sections du résumé

BACKGROUND & AIMS
Increased intestinal permeability has been associated with Crohn's disease (CD), but it is not clear whether it is a cause or result of the disease. We performed a prospective study to determine whether increased intestinal permeability is associated with future development of CD.
METHODS
We assessed the intestinal permeability, measured by the urinary fractional excretion of lactulose-to-mannitol ratio (LMR) at recruitment in 1420 asymptomatic first-degree relatives (6-35 years old) of patients with CD (collected from 2008 through 2015). Participants were then followed up for a diagnosis of CD from 2008 to 2017, with a median follow-up time of 7.8 years. We analyzed data from 50 participants who developed CD after a median of 2.7 years during the study period, along with 1370 individuals who remained asymptomatic until October 2017. We used the Cox proportional hazards model to evaluate time-related risk of CD based on the baseline LMR.
RESULTS
An abnormal LMR (>0.03) was associated with a diagnosis of CD during the follow-up period (hazard ratio, 3.03; 95% CI, 1.64-5.63; P = 3.97 × 10
CONCLUSIONS
Increased intestinal permeability is associated with later development of CD; these findings support a model in which altered intestinal barrier function contributes to pathogenesis. Abnormal gut barrier function might serve as a biomarker for risk of CD onset.

Identifiants

pubmed: 32791132
pii: S0016-5085(20)35021-6
doi: 10.1053/j.gastro.2020.08.005
pii:
doi:

Substances chimiques

Mannitol 3OWL53L36A
Lactulose 4618-18-2

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2092-2100.e5

Subventions

Organisme : CIHR
ID : CMF108031
Pays : Canada

Investigateurs

Maria Abreu (M)
Paul Beck (P)
Charles Bernstein (C)
Kenneth Croitoru (K)
Leo Dieleman (L)
Brian Feagan (B)
Anne Griffiths (A)
David Guttman (D)
Kevan Jacobson (K)
Gilaad Kaplan (G)
Denis O Krause (DO)
Karen Madsen (K)
John Marshall (J)
Paul Moayyedi (P)
Mark Ropeleski (M)
Ernest Seidman (E)
Mark Silverberg (M)
Scott Snapper (S)
Andy Stadnyk (A)
Hillary Steinhart (H)
Michael Surette (M)
Dan Turner (D)
Thomas Walters (T)
Bruce Vallance (B)
Guy Aumais (G)
Alain Bitton (A)
Maria Cino (M)
Jeff Critch (J)
Lee Denson (L)
Colette Deslandres (C)
Wael El-Matary (W)
Hans Herfarth (H)
Peter Higgins (P)
Hien Huynh (H)
Jeff Hyams (J)
David Mack (D)
Jerry McGrath (J)
Anthony Otley (A)
Remo Panancionne (R)
Guy Aumais (G)
Robert Baldassano (R)
Charles Bernstein (C)
Maria Cino (M)
Lee Denson (L)
Colette Deslandres (C)
Wael El-Matary (W)
Anne M Griffiths (AM)
Charlotte Hedin (C)
Hans Herfarth (H)
Peter Higgins (P)
Seamus Hussey (S)
Hien Hyams (H)
Kevan Jacobson (K)
David Keljo (D)
David Kevans (D)
Charlie Lees (C)
David Mack (D)
John Marshall (J)
Jerry McGrath (J)
Sanjay Murthy (S)
Anthony Otley (A)
Remo Panaccione (R)
Nimisha Parekh (N)
Sophie Plamondon (S)
Graham Radford-Smith (G)
Mark Ropeleski (M)
Joel Rosh (J)
David Rubin (D)
Michael Schultz (M)
Ernest Seidman (E)
Corey Siegel (C)
Scott Snapper (S)
Hillary Steinhart (H)
Dan Turner (D)

Informations de copyright

Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved.

Auteurs

Williams Turpin (W)

Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

Sun-Ho Lee (SH)

Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

Juan Antonio Raygoza Garay (JA)

Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

Karen L Madsen (KL)

University of Alberta, Edmonton, Alberta, Canada.

Jonathan B Meddings (JB)

Department of Medicine, Cumming School of Medicine, Calgary, Alberta, Canada.

Larbi Bedrani (L)

Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

Namita Power (N)

Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada.

Osvaldo Espin-Garcia (O)

Division of Biostatistics, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.

Wei Xu (W)

Division of Biostatistics, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.

Michelle I Smith (MI)

Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada.

Anne M Griffiths (AM)

Division of Gastroenterology, The Hospital for Sick Children, Toronto, Ontario, Canada.

Paul Moayyedi (P)

Department of Medicine, McMaster University, Farncombe Family Digestive Health Research Institute, Hamilton, Ontario, Canada.

Dan Turner (D)

The Juliet Keidan Institute of Pediatric Gastroenterology and Nutrition, Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Jerusalem, Israel.

Ernest G Seidman (EG)

Inflammatory Bowel Disease Centre, Division of Gastroenterology, McGill University Health Centre, Montréal, Quebec, Canada.

A Hillary Steinhart (AH)

Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

John K Marshall (JK)

Department of Medicine, McMaster University, Farncombe Family Digestive Health Research Institute, Hamilton, Ontario, Canada.

Kevan Jacobson (K)

Canadian Gastro-Intestinal Epidemiology Consortium, Canada; British Columbia Children's Hospital, Vancouver, British Columbia Children's Hospital Research Institute, University of British Columbia, Vancouver, British Columbia, Canada.

David Mack (D)

Division of Gastroenterology, Hepatology & Nutrition, Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, Ontario, Canada.

Hien Huynh (H)

Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.

Charles N Bernstein (CN)

University of Manitoba Inflammatory Bowel Disease Clinical and Research Centre and, Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Manitoba, Winnipeg, Canada.

Andrew D Paterson (AD)

Division of Biostatistics, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada; Genetics and Genome Biology, The Hospital for Sick Children Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada.

Kenneth Croitoru (K)

Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada; Department of Medicine, University of Toronto, Toronto, Ontario, Canada. Electronic address: Ken.Croitoru@sinaihealth.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH